Juergen Schmider

Papers

Total Citations

H-Index

About

Juergen Schmider is a leading figure in the application of artificial intelligence to pharmacovigilance, a critical field focused on monitoring the safety of pharmaceutical products. His most influential work, the 2018 paper "Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing," has garnered 86 citations and stands as a landmark study in the industry. In this research, Schmider demonstrated the feasibility of using AI and robotic process automation to streamline adverse event case processing—historically the most significant cost driver in pharmacovigilance budgets. By piloting these technologies, he showed how automation could dramatically improve efficiency, reduce human error, and accelerate safety reporting. This contribution has positioned him as a pioneer in digital pharmacovigilance, helping to shift the industry from manual, labor-intensive workflows toward intelligent, automated systems. His work not only offers practical solutions for pharmaceutical companies but also sets a foundation for future innovations in drug safety monitoring, making him an essential voice for researchers and students interested in the intersection of AI and healthcare compliance.